Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $111.5000 (-2.24%) ($110.5100 - $114.8000) on Mon. Apr. 23, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 40 | Latest Price | $111.5000(-2.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | UTHR declines -0.2% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XLV(44%) XBI(43%) VFMO(40%) VT(40%) | Factors Impacting UTHR price | UTHR will decline at least -1.375% in a week (0% probabilities). VIXM(-13%) TLT(-13%) UUP(-10%) VXX(-3%) DRIV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
Resistance Level | $111.98 | 5 Day Moving Average | $112.97(-1.3%) | 10 Day Moving Average | $112.59(-0.97%) | 20 Day Moving Average | $111.98(-0.43%) | To recent high | -21.9% | To recent low | 4% | Market Cap | $4.946b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |